MRGPRX2 Activation Causes Increased Skin Reactivity in Patients with Chronic Spontaneous Urticaria
- 6 August 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 141 (3), 678-681.e2
- https://doi.org/10.1016/j.jid.2020.06.030
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 15 references indexed in Scilit:
- Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2International Immunopharmacology, 2018
- Dual action of neurokinin-1 antagonists on Mas-related GPCRsJCI Insight, 2016
- Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactionsNature, 2014
- Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticariaJournal of Allergy and Clinical Immunology, 2014
- Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet needClinical & Experimental Allergy, 2014
- Cutaneous responses to substance P and calcitonin gene‐related peptide in chronic urticaria: the effect of cetirizine and dimethindeneAllergy, 1999
- Cutaneous responses to vasoactive intestinal polypeptide in chronic idiopathic urticariaThe Lancet, 1992
- Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.The Journal of Immunology, 1987
- Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticariaJournal of Allergy and Clinical Immunology, 1986
- Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells.The Journal of Immunology, 1985